-
Price Momentum
FTH is trading in the middle of its 52-week range and above its 200-day simple moving average.
-
Price change
The price of FTH shares has increased $1.17 since the market last closed. This is a 7.03% rise.
-
Closed at $17.82.
The stock has since dropped $0.40 in after-hours trading.
Key terms
About FTH
Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
-
Market cap: $23.91M
A market capitalization up to $300 million places FTH in the micro-capitalization category.
Key terms
Smart score
Latest FTH news
No recent press releases are available for FTH
FTH Financials
-
FTH total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$21.09M (1Y), -$170.24M (Q1)
Net Income increased 30.08% since last year and decreased 3508.99% since last quarter.
-
Earnings per share: -$16.72 (1Y), -$131.45 (Q1)
EPS increased 30.35% since last year and decreased 3415.39% since last quarter.
Key terms
FTH Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
FTH Competitors
-
How competitors are chosen
FTH's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $23.91M
A market capitalization up to $300 million places FTH in the micro-capitalization category.
